Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/06/2025 ,inter alia, to consider and approve To Consider & declare ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shukra Pharmaceuticals has informed BSE that its Board of Directors will meet on June 4, 2025 at the company's registered office in Ahmedabad. The main agenda item is to consider and declare a final dividend on the paid-up equity share capital for the financial year 2024-2025. Any other business may also be taken up with the Chairman's permission. The scrip code is 524632 and the letter is signed by Director Bhoomi (DIN: 08316896).
This is a routine pre-announcement ahead of a potential dividend declaration. Shareholders should wait for the board meeting outcome on June 4, 2025, to know the actual dividend amount and any record date that may follow.